Pfizer on track to post best monthly gain in nearly three decades
Despite a threat to vaccine-driven immunity with the recent emergence of the new COVID-19 variant Omicron,$Pfizer (PFE.US)$is on course to record its best monthly gain since Dec. 1991.
Over the past 12 months, the shares of the New York-based pharma giant has climbed ~40.8% well outperforming the broader index, as indicated in the graph below. Driven by the sales of the vaccine it co-developed with$BioNTech (BNTX.US)$, its revenue has more than doubled over the past year.
Pfizer’s performance contrasts with rival vaccine maker$Moderna (MRNA.US)$whose CEO has warned that the COVID-19 vaccines could lose efficacy against Omicron, classified by the World Health Organization (WHO) as a global variant of concern.
However, Pfizer targets both preventative and therapeutic aspects of the disease with its vaccine and the experimental COVID-19 pill Paxlovid, for which the company has already sought U.S. regulatory authorization.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Mooncity
:
Even if the Covid bonanza for PFE is short lived, it’s made PFE’s balance sheet as good as JNJ’s, JNJ being the Dividend King of drug stocks. I guess the market hasn’t figured out why PFE has been around for about 170 years, with about 330 consecutive quarters of dividends.
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Dr Wickers : Just raise the dividend bigly in a few weeks....
T_shares : PFE mmm-hmmmm, $60 soon?
Ciao
Mooncity : Even if the Covid bonanza for PFE is short lived, it’s made PFE’s balance sheet as good as JNJ’s, JNJ being the Dividend King of drug stocks. I guess the market hasn’t figured out why PFE has been around for about 170 years, with about 330 consecutive quarters of dividends.
James Browny : Are PFE executives selling to lock in their gains?
EEEEgil James Browny : A few are....
http://openinsider.com/search?q=pfe
Aaron_Kelly : Pandemic's are good business. Keep the variants coming!
wild horse : Imagine that!
ceerup : Well that’s not fabulous— after all its stock price has made zero progress over the last 20 years. Not good.
KNJW ceerup : That's why buy & hold is not always the best choice. Happy to be invested since this year.
Baby putsomemusic : Not that the writer said but, PFE is up 19.8% in the last month.
View more comments...